Feasibility and Acceptability of a Novel Implementation Intervention to Promote Alcohol Use Disorder Treatment in Hepatology Clinics
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Recruitment success to assess Feasibility
研究概览
简要总结
The goal of this project is to improve provision of integrated medications for alcohol use disorder (MAUD) with brief counseling for patients with alcohol use disorder (AUD) and alcohol-associated liver disease (ALD) in hepatology clinics. There are many benefits of AUD treatment among patients with AUD and ALD such as reduction in liver-related complications and hepatology clinicians providing this care in an integrated fashion can improve access and uptake.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Must provide care for patients with liver disease at a hepatology clinical location within the Yale School of Medicine and YNHH medical system.
排除标准
- •Providers who do not treat patients with chronic liver disease and alcohol-associated liver disease.
研究组 & 干预措施
Hepatology Clinicians
Clinician participants will participate in a multipronged intervention including hepatology clinician education, patient education, clinical decision support, and clinician audit and feedback which will be adapted and tested. Participants will attend two approximately 60-minute-long educational sessions in which key points related to AUD treatment based on the HPCR resource and implementation facilitation intervention will be reviewed.
干预措施: Implementation Intervention (Behavioral)
结局指标
主要结局
Recruitment success to assess Feasibility
时间窗: 3, 6 and 12 months
Percentage of clinicians enrolled out of all recruited
Educational Workshop Attendance to assess Feasibility
时间窗: 3, 6 and 12 months
Percentage of clinicians that attend the educational workshops
Clinician Decision Support Tool Use to assess Feasibility
时间窗: 3, 6 and 12 months
Percentage of visits involving patients with AUD and ALD in which the clinical decision support tool is used
Acceptability of Intervention Measure (AIM) to assess Acceptability
时间窗: 3, 6 and 12 months
4-item measure of perceived intervention acceptability. Total score 1-5 with higher scores indicating greater acceptability
次要结局
未报告次要终点